Trials / Completed
CompletedNCT02102503
Motivational Interviewing and Medication Review in Coronary Heart Disease
Motivational Interviewing and Medication Review in the Secondary Prevention of Coronary Heart Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 417 (actual)
- Sponsor
- Göran Petersson · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Low medication adherence in patients with coronary heart disease increases mortality. This study investigates if an intervention of medication review and counselling can improve patients' medication adherence and treatment results.
Detailed description
The study will investigate the effects of medication review and Motivational Interviewing (MI) on patients with Coronary Heart Disease (CHD). Clinical pharmacists competent in MI and cardiology will conduct medication interviews and medication reviews at the outpatient clinic. The intervention will continue during 9 months, with interviews and reviews as needed. Follow-up of results will take place 16 months after inclusion (corresponding to 4 months after the end of intervention). The MI-Component will be quality assured by MITI 4.2-coding (Motivational Interviewing Treatment Integrity). The study will investigate effects on clinical outcomes, medication adherence, patients´ beliefs about medicines and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standard Treatment | |
| BEHAVIORAL | MI and Medication review |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2014-04-03
- Last updated
- 2018-08-09
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02102503. Inclusion in this directory is not an endorsement.